Abstract

It is currently unknown how mucosal adjuvants cause induction of secretory immunoglobulin A (IgA), and how T cell-dependent (TD) or -independent (TI) pathways might be involved. Mucosal dendritic cells (DCs) are the primary antigen presenting cells driving TI IgA synthesis, by producing a proliferation-inducing ligand (APRIL), B cell activating factor (BAFF), Retinoic Acid (RA), TGF-β or nitric oxide (NO). We hypothesized that the mucosal adjuvant Cholera Toxin subunit B (CTB) could imprint non-mucosal DCs to induce IgA synthesis, and studied the mechanism of its induction. In vitro, CTB-treated bone marrow derived DCs primed for IgA production by B cells without the help of T cells, yet required co-signaling by different Toll-like receptor (TLR) ligands acting via the MyD88 pathway. CTB-DC induced IgA production was blocked in vitro or in vivo when RA receptor antagonist, TGF-β signaling inhibitor or neutralizing anti-TGF-β was added, demonstrating the involvement of RA and TGF-β in promoting IgA responses. There was no major involvement for BAFF, APRIL or NO. This study highlights that synergism between CTB and MyD88-dependent TLR signals selectively imprints a TI IgA-inducing capacity in non-mucosal DCs, explaining how CTB acts as an IgA promoting adjuvant.

Highlights

  • Secretory immunoglobulin A (SIgA) is abundantly present at mucosal surfaces of the gastrointestinal and respiratory tract

  • IgA induction by non-mucosal bone marrow derived (BM)-dendritic cells (DCs) was compared to bona fide mucosal PPDCs, representing the natural IgA inducing capacity of cells specialized in promoting this response

  • B cells exposed to Cholera Toxin subunit B (CTB) or LPS+CTB did not produce IgA, indicating that CTB did not act on B cells directly

Read more

Summary

Introduction

Secretory immunoglobulin A (SIgA) is abundantly present at mucosal surfaces of the gastrointestinal and respiratory tract. SIgA, prevents pathogens and commensal bacteria from binding to epithelial cells, it prevents ingested or inhaled allergens to cause immunopathology and it neutralizes toxins, broadly acting to maintain homeostasis in the gut and lung [1,2,3,4]. TI IgA synthesis is induced in polyclonal naıve B cells by dendritic cell (DC)- and epithelial cell- derived molecules, such as proliferationinducing ligand (APRIL), B cell activating factor (BAFF), Retinoic Acid (RA), TGF-b or nitric oxide (NO) [9,10,11]. Mucosal conditioning of DCs occurs via tissue-derived factors, such as RA and TGF-b, and by (commensal) bacteria expressing Toll-like receptor (TLR) ligands [13,14,15]

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.